|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Losartan potassium(XozaarTm) : A nonpeptide antagonist of angiotensin Ⅱ 显示文摘 | Smith RD Sweet CS Goldberg A | 1995 | Drugs Today1995，31，7： | 1 |
| 2 | Pharmacodynamic activity of intravenous E-3174,an angiotensinⅡantagonist,inpatients with essential hypertension显示文摘 | Sweet CS Bradstreet DC Berman RS | 1994 | Am J Hypertens1994，7，： | 1 |
| 3 | Losartan potassium (Cozaar TM):a nonpeptide antagonist of angiotensin Ⅱ显示文摘 | Smith RD Sweet CS | 1995 | J Drugs Today1995，31，7： | 1 |
| 4 | Increased survival in rats with congestive heart failure treated with enalapril显示文摘 | Emmert SE Stabilito Ⅱ | 1987 | J Cardiovasc Pharmacol1987，10，： | 1 |
| 5 | Safety and tolerability of can-desartan potassium,an angiotensin Ⅱ receptor antagonist,compared with hydrochlorothiazide,atenolol,felodipine ER,and angiotensin-coverting enzyme inhibitors for the treatment of systemic hyperten-sion显示文摘 | Goldberg AI Dunlay MC Sweet CS | 2005 | Am J Cardiol2005，75，： | 1 |
| 6 | Safety and tolerability of losartan potas-sium, an angiotensin Ⅱ receptor antagonist,compared with hydrochlorothiazide, antenolol ,felodipine ER, and angiotensin converting enzyme in-hibitors for the treatment of systemic hypetesion显示文摘 | Goldberg AL Dunlay MC Sweet CS | 1995 | Am J Cardiol1995，75，12： | 1 |
| 7 | Safety and tolerability of losartan potassium,an angiotensin Ⅱ receptor antagonist,compared with hydrochlorothiazide,atenolol,felodipine ER,and angiotensin-coverting enzyme inhibitors for the treatment of systemic hypertension显示文摘 | Goldberg AI Dunlay MC Sweet CS | | 0，，： | 1 |
| 8 | Safety and tolerability oflosartan potassium, an angiotensin Ⅱ receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER,and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension显示文摘 | Dunlay MC Sweet CS | 1995 | Am J Cardiol1995，75，： | 1 |
| 9 | Safety and tolerability of losartan potassium,a angiotensin Ⅱ receptro antagonist,compared with hydrochlorothiazide aienolol felodipine and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension显示文摘 | 1,Goldberg AI Dunlay MC Sweet CS | 1995 | Am J Cardio1995，75，12： | 1 |
| 10 | Safety and tolerability of Losartan potassium, an angiotensin Ⅱ receptor antagonist,compared with hydrochlorothiazide, atenolol, felodipine ER,and angiotensin-coverting enzyme inhibitors for the treatment ofsystemic hypertension显示文摘 | Goldberg AI Dunlay MC Sweet CS | 1995 | Am J Cardiol1995，72，： | 1 |
| 11 | Safety and tolerability oflosartan compared with atenolol,felodipine and angiotensin coverring enzyme inhibitors显示文摘 | Goldberg AI Dunlay MC Sweet CS | 1995 | J Hypertens1995，13，： | 1 |
| 12 | Phar- macodynamie activity of intravenous E-3174, an angio- tensin II antagonist, in patients with essential hyper- tension显示文摘 | Sweet CS Bradstreet DC Berman RS | 1994 | Am J Hypertens1994，7，12： | 1 |
| 13 | Safetg and tolerahilig of losarren potassium. an angiotensin Ⅱ receptor antegemist, comparedwith HCTZ, atenolol, felodipine ER, and angiotensin conversing enzgme inhibitors for thetreatmet of systemic hgpertension显示文摘 | Golderz Hi Dunlag MC Sweet CS | | 0，，： | 1 |
| 14 | Safety and tolerabitity of losartan compared with atenolo,felodipine and angiotensin converting enzyme inhibitors显示文摘 | Golderg AI Dunlay MC Sweet CS | 1995 | J Hypertens1995，13，1： | 1 |
| 15 | Safety and tolerability of losartan potassium : an angiotensin Ⅱ receptro antagonist, compared with hydrochlorothiazide aienolol felodipine and angiotensin2converting enzyme inhibitors for the treatment of systemic hypertension显示文摘 | Goldberg AI Dunlay MC Sweet CS | 1995 | Am J Cardio1995，75，12： | 1 |
| 16 | Issues surrounding a local cardiac renin system and the beneficial aceions of angiotension converting enzyme inhibitors in ischemia myocardium 显示文摘 | Sweet CS | 1990 | Am J Cardial1990，65，： | 1 |
| 17 | Safety and loterability of tosartan potassium,an angiotensin Ⅱ receptor antagonist,compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin - coverting enzyme inhibitors for the treatment of systemic hypertension显示文摘 | Goldberg AI Dunlay MC Sweet CS | 1995 | Am J Cardiol1995，75，： | 1 |
| 18 | Safety and tolerability of losartan potassium,an angiotensin Ⅱreceptor antagonist,compared with hydrochlorothiazide,atenolol,felodipine ER,and angiotensin-coverting enzyme inhibitors for the treatment of systemic hypertension显示文摘 | Goldberg AI Dunlay MC Sweet CS | 1995 | Am J Cardiol1995，75，12： | 1 |
| 19 | Safety and tolerability of losartan compared with atenolol,felodipine and angiotensin converting enzyme inhibitors显示文摘 | Goldberg Al MC Dunlay CS Sweet | 1995 | J Hypertens Suppl1995，13，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员